Medicaid dual eligibility
Medicaid dual eligibility has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jul 31, 2026: “Cardiovascular Multimorbidity and Associated Mortality Among Medicare Beneficiaries Dually Eligible for Medicaid”.
1 paper studies it3 findingsUpdated
See all 1 papers on medicaid dual eligibility
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Dual-eligible beneficiaries were more likely to develop CVD and multimorbidity and had higher mortality rates before and after adjustment.”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of medicaid dual eligibility find?
1Studies of medicaid dual eligibility measured 1 outcome; the most studied are mortality (1 study).
Mortality
upin humans1
1 study
Mortality
upin humans1
Medicaid dual eligibility is linked with higher mortality in humans (adjusted for demographics and comorbidity burden).
“Dual-eligible beneficiaries were more likely to develop CVD and multimorbidity and had higher mortality rates before and after adjustment.”
Humansadjusted for demographics and comorbidity burdenmedian 5 yearsn = 2,189,382
Journal of the American Heart Association
What is medicaid dual eligibility linked with?
2Studies link medicaid dual eligibility with 2 measures, most often cardiovascular multimorbidity (1 study) and cardiovascular disease (1).
Cardiovascular multimorbidity
upin humans1
1 study
Cardiovascular multimorbidity
upin humans1
Medicaid dual eligibility is linked with a higher risk of cardiovascular multimorbidity in humans (adjusted for demographics and comorbidity burden).
“Dual-eligible beneficiaries were more likely to develop CVD and multimorbidity and had higher mortality rates before and after adjustment.”
Humansadjusted for demographics and comorbidity burdenmedian 5 yearsn = 2,189,382
Journal of the American Heart Association
Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Medicaid dual eligibility is linked with a higher risk of cardiovascular disease in humans (adjusted for demographics and comorbidity burden).
“Dual-eligible beneficiaries were more likely to develop CVD and multimorbidity and had higher mortality rates before and after adjustment.”
Humansadjusted for demographics and comorbidity burdenmedian 5 yearsn = 2,189,382
Journal of the American Heart Association